KHK7580の第2相試験

基本情報

NCT ID: NCT02216656
ステータス: 完了
試験のフェーズ: 第2相
試験タイプ: 介入
目標被験者数: 201
治験依頼者名: Kyowa Kirin Co., Ltd.

概要

This randomized, placebo-controlled, double-blind (included open arm of KRN1493 (cinacalcet)), parallel-group, multi-center study is designed to evaluate efficacy and safety in cohorts comprising KHK7580, its placebo and KRN1493 (cinacalcet) orally administered for three weeks for secondary hyperparathyroidism patients receiving hemodialysis.

対象疾患

Secondary Hyperparathyroidism

介入

Placebo(DRUG)

KHK7580 low dose(DRUG)

KHK7580 middle dose(DRUG)

KHK7580 high dose(DRUG)

KRN1493(DRUG)

依頼者（Sponsor）

協和キリン株式会社(INDUSTRY)